Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
about
CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factorERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progressionGlycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response elementRedox regulation of FoxO transcription factorsAkt signaling dynamics in individual cells.Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factor Mcl-1FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttlingThe FoxO codeBoth the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA bindingFoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamicsFOXO transcription factors at the interface between longevity and tumor suppressionPP2A regulates the pro-apoptotic activity of FOXO1.Identification and analysis of evolutionary selection pressures acting at the molecular level in five forkhead subfamilies.Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1FOXO transcription factors: their clinical significance and regulation.Modelling the response of FOXO transcription factors to multiple post-translational modifications made by ageing-related signalling pathwaysPhosphorylation and acetylation modifications of FOXO3a: Independently or synergistically?Regulation of FOXO1 by TAK1-Nemo-like kinase pathwayProtein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.The FoxO family in cardiac function and dysfunction.PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cellsFOXO1: a potential target for human diseasesFoxO, autophagy, and cardiac remodeling.Mitochondrial longevity pathwaysA farnesylated G-protein suppresses Akt phosphorylation in INS 832/13 cells and normal rat islets: regulation by pertussis toxin and PGE₂.The many forks in FOXO's road.Insulin and LiCl synergistically rescue myogenic differentiation of FoxO1 over-expressed myoblastsDecisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.Deciphering the role of forkhead transcription factors in cancer therapyHepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.Nuclear transport and cancer: from mechanism to intervention.The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics.Surf the post-translational modification network of p53 regulationFoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c.The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IκB kinase β expression and localization.
P2860
Q24321230-68001056-6204-4243-8F72-A4458EBEB501Q24629604-27500609-913D-424D-8596-1BB567486E67Q24793511-339E142B-36F8-4FFF-ACE9-3C5698D2891CQ26799843-8AD144F4-216B-461A-88E1-C5A47EB9A738Q27340143-917691B6-F1B4-4639-B0B9-310FBC4A61F0Q28205486-5D3188FF-B9BA-42A6-9192-3DBCF7CAE2CBQ28258996-DAC93D46-4EE8-49BB-96FF-8CBEBA2C5CE6Q28275268-50711E5C-9A74-4D9D-B9E7-B9725DA83730Q28284616-1CC8D5ED-4072-4D92-83CC-D56E8648148BQ28504819-A73214CD-FD17-4FC9-8CAA-CE90C4959B48Q29620472-07EE64B9-26EB-4909-B1BD-2C9870BE5CBEQ30440004-3BB42255-200E-46B8-AA58-EA9BA724C0CEQ33371818-4DCD00B0-CBE4-4AD0-AD66-C123B78224CAQ33577496-710CBE8D-986D-4DC5-8A59-20AF56CA8C2CQ33594004-3F70C143-ED67-4908-992F-959FAEFA9398Q33612153-35EBE300-68A7-4D3A-9008-4B098E83CE90Q33685068-4B53B39B-E495-4372-954C-059BA2466280Q33707056-A5A45287-7FC3-4227-B613-398E1396737EQ33721192-7A0E95A8-B002-48B2-B694-85A690982D79Q33865096-6EB71C25-236D-4020-9877-C5C8A8949808Q34013124-993D5955-C1A5-4D41-9378-9A8061E3A266Q34121608-9B72D853-CC9E-4A93-AC09-6BEC92D49ED5Q34163416-F10D432C-2958-41B0-AD0A-7803769465E7Q34173809-A4836A01-2958-465B-8C30-8B8D97D5D821Q34362813-B68CD773-1067-429C-9177-28888A7D4998Q34767374-96878A5F-4102-4953-938B-D342046AA04CQ34884341-6FD72B69-0D7E-4376-8CA2-89996D9CBFBAQ35079447-DF75426B-B725-41FE-B432-B1E02F5F3979Q35097402-78D0BAAE-1909-48B1-9F21-72CB212A32B1Q35139549-CB5011AE-65DD-4D8B-A2F8-A6420C76326FQ35146638-56033EA2-17E2-4FCB-AED7-65CE92B0DE64Q35601144-4B7DBE31-04C9-4421-9547-BCFBE1AB34DAQ35633427-2611673C-826A-4AE5-9466-4FA14143BF12Q35684376-450E1579-7CB2-49DB-B306-3D3B480C833EQ35787179-3327A247-AD41-4061-AC92-FE05DD7B3B0DQ35865318-486E9BB4-152D-4C9D-917A-1784CFCD7170Q35967111-5E4D358C-5A29-4E8E-A912-592073468C3FQ36016844-D7FDF933-BB95-4036-A93D-94FA655C3A9EQ36095563-42477EDC-4522-4DF6-A792-5D9DE11AE6ACQ36305178-1FDF7C1A-A521-46DD-8A3C-26B4D49E3F10
P2860
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@ast
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@en
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@nl
type
label
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@ast
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@en
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@nl
prefLabel
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@ast
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@en
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@nl
P2093
P2860
P3181
P356
P1433
P1476
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
@en
P2093
Alan R Prescott
Mark Peggie
Michayla R Williams
Philip Cohen
Terry G Unterman
Yvonne L Woods
P2860
P304
P3181
P356
10.1093/EMBOJ/21.9.2263
P407
P50
P577
2002-05-01T00:00:00Z